Clinical trial
A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease
NCT00387075 · Institute for Neurodegenerative Disorders, Other · Unknown status
Key facts
| NCT number | NCT00387075 |
|---|---|
| Title | A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease |
| Official title | Parkinson Associated Risk Factor Study (PARS): Evaluating Potential Screening Tools for Parkinson Disease |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Collaborators | United States Department of Defense U.S. Fed Molecular NeuroImaging |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug, Procedure |
| Interventions | [123I]β-CIT and SPECT imaging, [123I]β-CIT |
| Enrollment | 3,000 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2023 |
| Completion | Aug 1, 2023 |
| First posted | Oct 12, 2006 |
| Last update posted | Mar 29, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: